Drug Database
Back to search

Poland· PL-100055618

Promazin Jelfa

A promazine product containing promazini hydrochloridum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 4 of our 19 countries.

ATC N05AA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPromazin JelfaATCN05AA03REGISTER NO.PL-100055618PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about promazini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Promazine is registered in 4 of 19 countries.

Countries holding a registration under ATC N05AA03 (promazine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose
Search promazine products by name

Promazine · ATC N05AA03

4 / 19 countries

  • Finlandprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of promazine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Promazine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Promazini hydrochloridum
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
N05AA03
ATC class
Promazine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990108015

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

344 interactions on record for promazine.

Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check promazine against other medicinesHow interaction checks work

Promazine · interactions on record

344 records

  • 46 severe
  • 262 moderate
  • 8 minor

Most severe, free to view

  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe

28 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Promazine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All promazine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Promazine Hydrochloride Aristo, Promazine Hydrochloride Glenmark Pharmaceuticals Europe
  • Croatia · Prazine, Promazin Belupo
  • Italy · Promazina Doc, Promazina Eg
  • Slovenia · Prazine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b6260152-eb55-4fb7-8252-6ac38299c512
GET /v1/drugs/b6260152-eb55-4fb7-8252-6ac38299c512?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "25 mg",
  "packaging": "Rp ¦ Skasowane ¦ 8326\n20 draż. \nRp ¦ Skasowane ¦ 8327\n250 draż. \n05909990108015 ¦ Rp ¦ 48304\n60 tabl.",
  "substance": "Promazini hydrochloridum 25 mg",
  "common_name": "Promazini hydrochloridum",
  "pl_product_id": "100055618",
  "pozwolenie_nr": "01080",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about promazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console